Protein name:
Sodium channel protein type 8 subunit alpha ;
Alternative:
Voltage-gated sodium channel subunit alpha Nav1.6 ;Sodium channel protein type VIII subunit alpha ;
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
Interacts with NEDD4 and NEDD4L.
Function:
Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient. In macrophages and melanoma cells, isoform 5 may participate in the control of podosome and invadopodia formation.
Subcellular Location:
Isoform 5
Cytoplasmic vesicle
Some vesicles are localized adjacent to melanoma invadopodia and macrophage podosomes. Does not localize to the plasma membrane.
Protein Attributes:
50:
MAARLLAPPG | PDSFKPFTPE | SLANIERRIA | ESKLKKPPKA | DGSHREDDED |
100:
SKPKPNSDLE | AGKSLPFIYG | DIPQGLVAVP | LEDFDPYYLT | QKTFVVLNRG |
150:
KTLFRFSATP | ALYILSPFNL | IRRIAIKILI | HSVFSMIIMC | TILTNCVFMT |
200:
FSNPPDWSKN | VEYTFTGIYT | FESLVKIIAR | GFCIDGFTFL | RDPWNWLDFS |
250:
VIMMAYITEF | VNLGNVSALR | TFRVLRALKT | ISVIPGLKTI | VGALIQSVKK |
300:
LSDVMILTVF | CLSVFALIGL | QLFMGNLRNK | CVVWPINFNE | SYLENGTKGF |
350:
DWEEYINNKT | NFYTVPGMLE | PLLCGNSSDA | GQCPEGYQCM | KAGRNPNYGY |
400:
TSFDTFSWAF | LALFRLMTQD | YWENLYQLTL | RAAGKTYMIF | FVLVIFVGSF |
450:
YLVNLILAVV | AMAYEEQNQA | TLEEAEQKEA | EFKAMLEQLK | KQQEEAQAAA |
500:
MATSAGTVSE | DAIEEEGEEG | GGSPRSSSEI | SKLSSKSAKE | RRNRRKKRKQ |
550:
KELSEGEEKG | DPEKVFKSES | EDGMRRKAFR | LPDNRIGRKF | SIMNQSLLSI |
600:
PGSPFLSRHN | SKSSIFSFRG | PGRFRDPGSE | NEFADDEHST | VEESEGRRDS |
650:
LFIPIRARER | RSSYSGYSGY | SQGSRSSRIF | PSLRRSVKRN | STVDCNGVVS |
700:
LIGGPGSHIG | GRLLPEATTE | VEIKKKGPGS | LLVSMDQLAS | YGRKDRINSI |
750:
MSVVTNTLVE | ELEESQRKCP | PCWYKFANTF | LIWECHPYWI | KLKEIVNLIV |
800:
MDPFVDLAIT | ICIVLNTLFM | AMEHHPMTPQ | FEHVLAVGNL | VFTGIFTAEM |
850:
FLKLIAMDPY | YYFQEGWNIF | DGFIVSLSLM | ELSLADVEGL | SVLRSFRLLR |
900:
VFKLAKSWPT | LNMLIKIIGN | SVGALGNLTL | VLAIIVFIFA | VVGMQLFGKS |
950:
YKECVCKINQ | DCELPRWHMH | DFFHSFLIVF | RVLCGEWIET | MWDCMEVAGQ |
1000:
AMCLIVFMMV | MVIGNLVVLN | LFLALLLSSF | SADNLAATDD | DGEMNNLQIS |
1050:
VIRIKKGVAW | TKLKVHAFMQ | AHFKQREADE | VKPLDELYEK | KANCIANHTG |
1100:
ADIHRNGDFQ | KNGNGTTSGI | GSSVEKYIID | EDHMSFINNP | NLTVRVPIAV |
1150:
GESDFENLNT | EDVSSESDPE | GSKDKLDDTS | SSEGSTIDIK | PEVEEVPVEQ |
1200:
PEEYLDPDAC | FTEGCVQRFK | CCQVNIEEGL | GKSWWILRKT | CFLIVEHNWF |
1250:
ETFIIFMILL | SSGALAFEDI | YIEQRKTIRT | ILEYADKVFT | YIFILEMLLK |
1300:
WTAYGFVKFF | TNAWCWLDFL | IVAVSLVSLI | ANALGYSELG | AIKSLRTLRA |
1350:
LRPLRALSRF | EGMRVVVNAL | VGAIPSIMNV | LLVCLIFWLI | FSIMGVNLFA |
1400:
GKYHYCFNET | SEIRFEIEDV | NNKTECEKLM | EGNNTEIRWK | NVKINFDNVG |
1450:
AGYLALLQVA | TFKGWMDIMY | AAVDSRKPDE | QPKYEDNIYM | YIYFVIFIIF |
1500:
GSFFTLNLFI | GVIIDNFNQQ | KKKFGGQDIF | MTEEQKKYYN | AMKKLGSKKP |
1550:
QKPIPRPLNK | IQGIVFDFVT | QQAFDIVIMM | LICLNMVTMM | VETDTQSKQM |
1600:
ENILYWINLV | FVIFFTCECV | LKMFALRHYY | FTIGWNIFDF | VVVILSIVGM |
1650:
FLADIIEKYF | VSPTLFRVIR | LARIGRILRL | IKGAKGIRTL | LFALMMSLPA |
1700:
LFNIGLLLFL | VMFIFSIFGM | SNFAYVKHEA | GIDDMFNFET | FGNSMICLFQ |
1750:
ITTSAGWDGL | LLPILNRPPD | CSLDKEHPGS | GFKGDCGNPS | VGIFFFVSYI |
1800:
IISFLIVVNM | YIAIILENFS | VATEESADPL | SEDDFETFYE | IWEKFDPDAT |
1850:
QFIEYCKLAD | FADALEHPLR | VPKPNTIELI | AMDLPMVSGD | RIHCLDILFA |
1900:
FTKRVLGDSG | ELDILRQQME | ERFVASNPSK | VSYEPITTTL | RRKQEEVSAV |
1950:
VLQRAYRGHL | ARRGFICKKT | TSNKLENGGT | HREKKESTPS | TASLPSYDSV |
1980:
TKPEKEKQQR | AEEGRRERAK | RQKEVRESKC |
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Rat
Mouse
Human
ELISA Kit for Human Sodium channel protein type 8 subunit alpha
ELISA Kit for Human Sodium channel protein type 8 subunit alpha
ELISA Kit for Human Sodium channel protein type 8 subunit alpha
CLIA Kit for Human Sodium channel protein type 8 subunit alpha
CLIA Kit for Human Sodium channel protein type 8 subunit alpha
CLIA Kit for Human Sodium channel protein type 8 subunit alpha
Polyclonal Antibody for Human Sodium channel protein type 8 subunit alpha
Polyclonal Antibody for Human Sodium channel protein type 8 subunit alpha
Polyclonal Antibody for Human Sodium channel protein type 8 subunit alpha
Monoclonal Antibody for Human Sodium channel protein type 8 subunit alpha
Monoclonal Antibody for Human Sodium channel protein type 8 subunit alpha
Monoclonal Antibody for Human Sodium channel protein type 8 subunit alpha
Protein for Human Sodium channel protein type 8 subunit alpha
Protein for Human Sodium channel protein type 8 subunit alpha
Protein for Human Sodium channel protein type 8 subunit alpha
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE (ISOFORM 4)
tissue :
Brain .
tissue :
Fetal brain .
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2 AND 3)
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5);FUNCTION;SUBCELLULAR LOCATION;TISSUE SPECIFICITY
tissue :
Monocytic leukemia .
4.
"cDNA sequence of human sodium channel, SCN8A."
Lin C.
,
Numakura C.
,
Kiyoshi H.
Submitted (1999-06) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
5.
"Cloning of cDNA for human voltage-gated sodium channel alpha subunit, SCN8A."
Jeong S.-Y.
,
Goto J.
,
Kanazawa I.
Submitted (2000-01) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
6.
"The finished DNA sequence of human chromosome 12."
Scherer S.E.
,
Muzny D.M.
,
Buhay C.J.
,
Chen R.
,
Cree A.
,
Ding Y.
,
Dugan-Rocha S.
,
Gill R.
,
Gunaratne P.
,
Harris R.A.
,
Hawes A.C.
,
Hernandez J.
,
Hodgson A.V.
,
Hume J.
,
Jackson A.
,
Khan Z.M.
,
Kovar-Smith C.
,
Lewis L.R.
,
Lozado R.J.
,
Metzker M.L.
,
Milosavljevic A.
,
Miner G.R.
,
Montgomery K.T.
,
Morgan M.B.
,
Nazareth L.V.
,
Scott G.
,
Sodergren E.
,
Song X.-Z.
,
Steffen D.
,
Lovering R.C.
,
Wheeler D.A.
,
Worley K.C.
,
Yuan Y.
,
Zhang Z.
,
Adams C.Q.
,
Ansari-Lari M.A.
,
Ayele M.
,
Brown M.J.
,
Chen G.
,
Chen Z.
,
Clerc-Blankenburg K.P.
,
Davis C.
,
Delgado O.
,
Dinh H.H.
,
Draper H.
,
Gonzalez-Garay M.L.
,
Havlak P.
,
Jackson L.R.
,
Jacob L.S.
,
Kelly S.H.
,
Li L.
,
Li Z.
,
Liu J.
,
Liu W.
,
Lu J.
,
Maheshwari M.
,
Nguyen B.-V.
,
Okwuonu G.O.
,
Pasternak S.
,
Perez L.M.
,
Plopper F.J.H.
,
Santibanez J.
,
Shen H.
,
Tabor P.E.
,
Verduzco D.
,
Waldron L.
,
Wang Q.
,
Williams G.A.
,
Zhang J.
,
Zhou J.
,
Allen C.C.
,
Amin A.G.
,
Anyalebechi V.
,
Bailey M.
,
Barbaria J.A.
,
Bimage K.E.
,
Bryant N.P.
,
Burch P.E.
,
Burkett C.E.
,
Burrell K.L.
,
Calderon E.
,
Cardenas V.
,
Carter K.
,
Casias K.
,
Cavazos I.
,
Cavazos S.R.
,
Ceasar H.
,
Chacko J.
,
Chan S.N.
,
Chavez D.
,
Christopoulos C.
,
Chu J.
,
Cockrell R.
,
Cox C.D.
,
Dang M.
,
Dathorne S.R.
,
David R.
,
Davis C.M.
,
Davy-Carroll L.
,
Deshazo D.R.
,
Donlin J.E.
,
D'Souza L.
,
Eaves K.A.
,
Egan A.
,
Emery-Cohen A.J.
,
Escotto M.
,
Flagg N.
,
Forbes L.D.
,
Gabisi A.M.
,
Garza M.
,
Hamilton C.
,
Henderson N.
,
Hernandez O.
,
Hines S.
,
Hogues M.E.
,
Huang M.
,
Idlebird D.G.
,
Johnson R.
,
Jolivet A.
,
Jones S.
,
Kagan R.
,
King L.M.
,
Leal B.
,
Lebow H.
,
Lee S.
,
LeVan J.M.
,
Lewis L.C.
,
London P.
,
Lorensuhewa L.M.
,
Loulseged H.
,
Lovett D.A.
,
Lucier A.
,
Lucier R.L.
,
Ma J.
,
Madu R.C.
,
Mapua P.
,
Martindale A.D.
,
Martinez E.
,
Massey E.
,
Mawhiney S.
,
Meador M.G.
,
Mendez S.
,
Mercado C.
,
Mercado I.C.
,
Merritt C.E.
,
Miner Z.L.
,
Minja E.
,
Mitchell T.
,
Mohabbat F.
,
Mohabbat K.
,
Montgomery B.
,
Moore N.
,
Morris S.
,
Munidasa M.
,
Ngo R.N.
,
Nguyen N.B.
,
Nickerson E.
,
Nwaokelemeh O.O.
,
Nwokenkwo S.
,
Obregon M.
,
Oguh M.
,
Oragunye N.
,
Oviedo R.J.
,
Parish B.J.
,
Parker D.N.
,
Parrish J.
,
Parks K.L.
,
Paul H.A.
,
Payton B.A.
,
Perez A.
,
Perrin W.
,
Pickens A.
,
Primus E.L.
,
Pu L.-L.
,
Puazo M.
,
Quiles M.M.
,
Quiroz J.B.
,
Rabata D.
,
Reeves K.
,
Ruiz S.J.
,
Shao H.
,
Sisson I.
,
Sonaike T.
,
Sorelle R.P.
,
Sutton A.E.
,
Svatek A.F.
,
Svetz L.A.
,
Tamerisa K.S.
,
Taylor T.R.
,
Teague B.
,
Thomas N.
,
Thorn R.D.
,
Trejos Z.Y.
,
Trevino B.K.
,
Ukegbu O.N.
,
Urban J.B.
,
Vasquez L.I.
,
Vera V.A.
,
Villasana D.M.
,
Wang L.
,
Ward-Moore S.
,
Warren J.T.
,
Wei X.
,
White F.
,
Williamson A.L.
,
Wleczyk R.
,
Wooden H.S.
,
Wooden S.H.
,
Yen J.
,
Yoon L.
,
Yoon V.
,
Zorrilla S.E.
,
Nelson D.
,
Kucherlapati R.
,
Weinstock G.
,
Gibbs R.A.
more...
Nature440:346-351(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
7.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH FGF13
8.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INVOLVEMENT IN CIAT
9.
"de novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP."
Veeramah K.R.
,
O'Brien J.E.
,
Meisler M.H.
,
Cheng X.
,
Dib-Hajj S.D.
,
Waxman S.G.
,
Talwar D.
,
Girirajan S.
,
Eichler E.E.
,
Restifo L.L.
,
Erickson R.P.
,
Hammer M.F.
Am. J. Hum. Genet.90:502-510(2012)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT EIEE13 ASP-1768;CHARACTERIZATION OF VARIANT EIEE13 ASP-1768
10.
"De novo SCN8A mutation identified by whole-exome sequencing in a boy with neonatal epileptic encephalopathy, multiple congenital anomalies, and movement disorders."
Vaher U.
,
Noukas M.
,
Nikopensius T.
,
Kals M.
,
Annilo T.
,
Nelis M.
,
Ounap K.
,
Reimand T.
,
Talvik I.
,
Ilves P.
,
Piirsoo A.
,
Seppet E.
,
Metspalu A.
,
Talvik T.
J. Child Neurol.0:0-0(2013)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT EIEE13 VAL-1327
11.
"Early onset epileptic encephalopathy caused by de novo SCN8A mutations."
Ohba C.
,
Kato M.
,
Takahashi S.
,
Lerman-Sagie T.
,
Lev D.
,
Terashima H.
,
Kubota M.
,
Kawawaki H.
,
Matsufuji M.
,
Kojima Y.
,
Tateno A.
,
Goldberg-Stern H.
,
Straussberg R.
,
Marom D.
,
Leshinsky-Silver E.
,
Nakashima M.
,
Nishiyama K.
,
Tsurusaki Y.
,
Miyake N.
,
Tanaka F.
,
Matsumoto N.
,
Saitsu H.
more...
Epilepsia55:994-1000(2014)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS EIEE13 ASP-216; SER-846; LYS-1466; THR-1466; GLN-1617; THR-1650 AND TRP-1872